Information for COPD Support groups  for the benefit of the COPD patient
Home   FAQ Contact  

COPD Council
131 DW Highway #627
Nashua, NH 03060

Email Addresses:


Calendar Information:

Speaker Information:

Print this Page


Check here for all
the latest COPD
related news

   Latest Event News

NEWS RELEASE RIDGEFIELD, CT (February 2, 2004) -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the United States Food and Drug Administration (FDA) has approved Spiriva® HandiHaler® (tiotropium bromide inhalation powder) for the long-term, once-daily maintenance treatment of bronchospasm associated with Chronic Obstructive Pulmonary Disease (COPD). see news release at:

Copyright 2003-2011